solid tumors

CAMBRIDGE, Mass., U.S., Aug 28, 2026 CREATE Medicines, Inc. announced a strategic research and development collaboration and license agreement...

SHANGHAI, CHINA, Aug 28, 2026 Duality Biotherapeutics, Inc. (DualityBio) has entered into a global collaboration and license agreement with...

NATICK, MASSACHUSETTS, AND RENO, NEVADA, Aug 27, 2026 Pillar Biosciences, Inc. and Hamilton Company have announced the validation and...

REDWOOD CITY, Calif. – August 27, 2026 Adicet Bio, Inc. announced that the U.S. Food and Drug Administration (FDA)...

Fort Myers, Florida – August 26, 2026 NeoGenomics announced that its RaDaR ST molecular residual disease (MRD) assay has...

Austin, Texas – August 27, 2026 Natera and Angiex have entered a new collaboration to assess treatment response to...

Tokyo, Japan – August 27, 2026 Daiichi Sankyo has entered a new phase of oncology development with the first...

Hong Kong, August 21, 2026 Akeso, Inc. has announced that its investigational B7-H3-targeting antibody-drug conjugate (ADC), AK157D1, has received...

Uppsala and Garching/Munich, August 20, 2026 Akiram Therapeutics has entered into a Lutetium-177 (Lu-177) supply agreement with ITM Isotope...

PRINCETON, New Jersey, August 20, 2026 UroGen Pharma Ltd. announced a strategic collaboration and investment agreement with IntraGel Therapeutics,...